SEC Filing | Colgate-Palmolive Company

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Groener David R

(Last)

(First)

(Middle)

COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/10/2008

3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP-Global Supply Chain

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	33,510	D
Common Stock	6,744	I	By Issuer's 401(k) Plan Trustee
Series B Convertible Preference Stock	2,823	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series B Convertible Preference Stock Units	⁽¹⁾	⁽¹⁾	Series B Convertible Preference Stock	142	0	D
Stock Option (Right to Buy)	09/10/2001⁽²⁾	09/10/2008	Common Stock	6,800	33.7344	D
Stock Option (Right to Buy)	09/09/2002⁽²⁾	09/09/2009	Common Stock	14,000	55.6563	D
Stock Option (Right to Buy)	09/09/2006⁽²⁾	09/09/2009	Common Stock	20,000	55.6563	D
Stock Option (Right to Buy)	09/14/2003⁽²⁾	09/14/2010	Common Stock	15,000	48.0625	D
Stock Option (Right to Buy)	09/17/2004⁽²⁾	09/17/2011	Common Stock	16,000	56.675	D
Stock Option (Right to Buy)	09/12/2005⁽²⁾	09/12/2012	Common Stock	20,000	55.11	D
Stock Option (Right to Buy)	09/11/2006⁽²⁾	09/11/2009	Common Stock	19,800	56.565	D
Stock Option (Right to Buy)	09/09/2007⁽²⁾	09/09/2010	Common Stock	21,000	54.4	D
Stock Option (Right to Buy)	09/08/2006⁽³⁾	09/08/2011	Common Stock	22,500	53.455	D
Stock Option (Right to Buy)	09/07/2007⁽³⁾	09/07/2012	Common Stock	24,000	60.68	D
Stock Option (Right to Buy)	09/12/2008⁽³⁾	09/12/2013	Common Stock	26,000	68.15	D

Explanation of Responses:

1. The reported preference stock units were acquired under the issuer's Supplemental Savings & Investment Plan and will be settled upon the reporting person's retirement or other termination of service.

2. Option became 100% exercisable on the date shown in this column.

3. Option becomes exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.

Remarks:

	Nina D. Gillman by power of attorney	01/17/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


POWER OF ATTORNEY

FORMS 3, 4 AND 5

I, David R. Groener, an officer of Colgate-Palmolive Company
(the "Company"), do hereby appoint Andrew D. Hendry, Nina D. Gillman,
Nina R. Huffman and J. Thomas Yust, severally, as my true and lawful
attorneys with the power to execute and file on my behalf and in my
place and stead,as I myself could do if I were personally present,
any Form 3, 4 or 5 to be filed by me pursuant to Section 16(a) of
the Securities Exchange Act of 1934 in connection with my ownership,
either directly or indirectly, or any change therein, of securities
of the Company.

This Power of Attorney shall remain in force and effect for
as long as I continue to be an officer of the Company or until earlier
revoked by me in writing and shall not otherwise be affected by my
subsequent disability or incompetence.

In witness whereof, I have signed this instrument
on January 11, 2008.



Signature:  /s/ David R. Groener
Print Name:    David R. Groener